Inventor · disambiguated record
Shanthi Ganesh
Also filed as: GANESH SHANTHI
11 granted patents·8 pending applications·24 citations·filing 2005–2025
86Inventor score
Files withDICERNA PHARMACEUTICALS INC10ARROWHEAD PHARMACEUTICALS INC2ARROWHEAD RES CORPORATION1HALLENBECK PAUL1NEOTROPIX INC1
Top patents by PatentIndex Score
19 records- 0186US8039606B2Seneca Valley virus based compositions and methods for treating diseaseNOVARTIS AG·Filed 2009·Granted Oct 18, 2011·6 cites·3 claims
- 0283US8753622B2Seneca valley virus based compositions and methods for treating diseaseHALLENBECK PAUL·Filed 2011·Granted Jun 17, 2014·5 cites·5 claims
- 0380US10821112B2Compositions and methods for the treatment of a beta-catenin-associated disease or disorderDICERNA PHARMACEUTICALS INC·Filed 2017·Granted Nov 3, 2020·1 cites·23 claims
- 0480US7638318B2Seneca Valley virus based compositions and methods for treating diseaseNORVARTIS AG·Filed 2006·Granted Dec 29, 2009·6 cites·9 claims
- 0575US9868949B2Organic compositions to treat EPAS1-related diseasesARROWHEAD RES CORPORATION·Filed 2014·Granted Jan 16, 2018·5 cites·20 claims
- 0674US2023190753A1Compositions and methods for the treatment of a beta-catenin-associated disease or disorderDICERNA PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0773US10538765B2Organic compositions to treat EPAS1-related diseasesARROWHEAD PHARMACEUTICALS INC·Filed 2017·Granted Jan 21, 2020·1 cites·19 claims
- 0872US2023392148A1Reducing beta-catenin expression to potentiate immunotherapyDICERNA PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0970US11504374B2Compositions and methods for the treatment of a beta-catenin-associated disease or disorderDICERNA PHARMACEUTICALS INC·Filed 2020·Granted Nov 22, 2022·0 cites·19 claims
- 1067US11261444B2Organic compositions to treat EPAS1-related diseasesARROWHEAD PHARMACEUTICALS INC·Filed 2020·Granted Mar 1, 2022·0 cites·17 claims
- 1165US11572559B2Reducing beta-catenin expression to potentiate immunotherapyDICERNA PHARMACEUTICALS INC·Filed 2018·Granted Feb 7, 2023·0 cites·29 claims
- 1262US11008571B2Beta catenin nucleic acid inhibitor moleculeDICERNA PHARMACEUTICALS INC·Filed 2018·Granted May 18, 2021·0 cites·18 claims
- 1362US2024124875A1Rnai conjugates and uses thereofDICERNA PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1461US2021238603A1Beta catenin nucleic acid inhibitor moleculeDICERNA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1561US2014348798A1Seneca valley virus based compositions and methods for treating diseaseNEOTROPIX INC·Filed 2014·Application pending·0 cites
- 1660US11813280B2Reducing beta-catenin and IDO expression to potentiate immunotherapyDICERNA PHARMACEUTICALS INC·Filed 2019·Granted Nov 14, 2023·0 cites·40 claims
- 1757US2025290071A1Stat3 targeting oligonucleotides and uses thereofNOVO NORDISK AS·Filed 2025·Application pending·0 cites
- 1850US2022154189A1Compositions and methods for the treatment of kras associated diseases or disordersDICERNA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1936US2006062764A1Fiber-modified adenoviral vectors for enhanced transduction of tumor cellsPOLICE SESHIDAR-REDDY·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shanthi Ganesh files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →